beta-Lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid.

Antimicrobial Agents and Chemotherapy
T Farmer, C Reading

Abstract

Three of four clinical isolates of Branhamella catarrhalis from Belgium produced a beta-lactamase identical to enzymes previously reported to occur in French and British isolates of this organism. One strain, however, produced a new type of beta-lactamase. Both beta-lactamase types were readily inhibited by low concentrations of clavulanic acid.

Citations

Aug 26, 1998·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·K McGregorT V Riley
Apr 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·I EliassonS G Waley
Dec 1, 1986·European Journal of Clinical Microbiology·B O Liljequist, L Gezelius
Nov 1, 1995·Research in Microbiology·E B ChaïbiJ F Acar
Aug 1, 1997·Natural Product Reports·K H BaggaleyC J Schofield
Jan 1, 1991·Microbiology and Immunology·T Takenouchi, T Nishino
Dec 24, 1997·Journal of Clinical Periodontology·H TenenbaumM Dahan
Jul 1, 1996·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·T Ejlertsen, R Skov
Jan 1, 1985·Antimicrobial Agents and Chemotherapy·C PintadoC Nombela
Apr 1, 1986·Antimicrobial Agents and Chemotherapy·E YokotaS Mitsuhashi
Mar 1, 1989·Antimicrobial Agents and Chemotherapy·K Bush
Jun 1, 1995·Antimicrobial Agents and Chemotherapy·K BushA A Medeiros
Mar 15, 1997·Medizinische Klinik·W Cullmann
Jan 1, 1982·Scottish Medical Journal·M Cole
Oct 1, 1990·Clinical Microbiology Reviews·B W Catlin
Jan 1, 1988·Clinical Microbiology Reviews·K Bush
Apr 1, 1996·Antimicrobial Agents and Chemotherapy·H J BootsmaF R Mooi

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.